The highest advisor of the Trump administration’s Operation Warp Pace predicted on Tuesday that Johnson & Johnson would search approval for its single-shot COVID-19 vaccine candidate later this month — and that it might get the greenlight in February.
Dr. Moncef Slaoui stated that he anticipated that the pharmaceutical large would have sufficient information from its late-stage trials to use for emergency use authorization from the Meals and Drug Administration in late January.
“If [the] submission is going on on the finish of January, one might mission that approval of the emergency use authorization might occur someplace in the midst of February,” Slaoui stated at a press convention.
Slaoui stated if the drug is permitted, they might start to distribute a lot of doses that month someplace within the “single-digit hundreds of thousands.”
“We are attempting to make that quantity as near a double-digit quantity [in the millions] as attainable after which a bigger quantity in March and far bigger quantity in April,” Slaoui stated.
“It is a one-shot vaccine so that’s hundreds of thousands of people absolutely immunized,” he added.
The Meals and Drug Administration has already permitted vaccines from Pfizer and Moderna, although each contain a two-shot routine.
